| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Steris (NYSE:STE) reported its Q2 earnings results on Tuesday, November 7, 2023 at 04:30 PM.
Here's what investors need to know about the announcement.
Steris beat estimated earnings by 1.0%, reporting an EPS of $2.03 versus an estimate of $2.01.
Revenue was up $141.00 million from the same period last year.
Last quarter the company beat on EPS by $0.14 which was followed by a 1.69% increase in the share price the next day.
Here's a look at Steris's past performance:
| Quarter | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|
| EPS Estimate | 1.86 | 2.15 | 2.19 | 1.98 |
| EPS Actual | 2 | 2.30 | 2.02 | 1.99 |
| Revenue Estimate | 1.19B | 1.27B | 1.27B | 1.22B |
| Revenue Actual | 1.28B | 1.39B | 1.22B | 1.20B |
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Steris management provided guidance for FY 2024, expecting earnings between $8.6 and $8.8 per share.
To track all earnings releases for Steris visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: STE
